International Clinical Trial: A multicenter retrospective observational study of real-world T-DXd treatment for stage4 HER2-mutated non-small cell lung cancer patients in Japan (REAL-HER2 Study) (WJOG21224L)

Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (JPRN-UMIN000059178) titled 'A multicenter retrospective observational study of real-world T-DXd treatment for stage4 HER2-mutated non-small cell lung cancer patients in Japan (REAL-HER2 Study) (WJOG21224L)' on Sept. 25.

Study Type: Observational

Study Design: Not selected Not selected

Primary Sponsor: West Japan Oncology Group

Condition: Lung Cancer

Recruitment Status: Not Recruiting

Phase: Not selected

Date of First Enrollment: 2026/01/31

Target Sample Size: 70

Countries of Recruitment: Japan

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066622

Published by HT Digital Content S...